Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aripiprazole LAI in Schizophrenia (ARILAI)
NCT02697045Phase 4Completed
- Start
- Jan 2017
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of aripiprazole in schizophrenia. Started Jan 2017; status: completed.
02
Drugs
aripiprazole
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT02697045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02697045.